RELATIONSHIP BETWEEN ESTROGEN RECEPTOR AND CLINICAL CHARACTERISTICS OF SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS

Thị Thu Hiền Đỗ, Văn Trung Lê, Trọng Tuỳ Thân

Main Article Content

Abstract

Objective: To investigate the relationship between the presence of estrogen receptor α (ERα) in the skin lesions and clinical characteristics of patients with systemic lupus erythematosus (SLE).Subjects and methods: This is a case seriers of 65 female patients diagnosed with systemic lupus erythematosus at the National Dermatology Hospital from January 2022 to August 2023. Clinical charactereristics were examined in all 65 patients. Histopathological examination and immunohistochemical staining was conducted among 36 of 65 patients to detect the presence of ERα in the skin lesions. Results: The average age of SLE patients was 30.72±15.1. Acute skin lesions are the most common, accounting for 60%, followed by subacute skin lesions (27.7%) and chronic skin lesions (12.3%). Among specific skin lesions, butterfly rash is the most common (36.9%), while photosensitivity is the most common non-specific skin lesions (52.3%). ERα was positive in 38.9% of cases and negative in 61.1% of cases. There is no relationship between ERα receptor and age group, classification of lupus erythematosus, specific skin lesions and non-specific skin lesions. Conclusion: In our study, skin lesions are very common and diverse in patients with systemic lupus erythematosus. The presence of ERα in skin lesions was detected in 38.9% of SLE cases. No association was found between the presence of ERα in skin lesions and clinical characteristics of SLE patients.

Article Details

References

1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006; 15(5): 308-318. doi:10.1191/ 0961203306lu2305xx
2. Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev. 1996;17(4):369-384. doi: 10.1210/edrv-17-4-369
3. Petri M, Robinson C. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum. 1997;40(5):797-803. doi:10.1002/art.1780400504
4. Yang LY, Huang WJ, Chen WP, Fu LW, Lin CY. Does parenteral oestrogen therapy flare up disease activity in patients with systemic lupus erythematosus complicated by haemorrhagic cystitis? Rheumatology. 1999;38(4):372-373.
5. Casoli P, Tumiati B, La Sala G. Fatal exacerbation of systemic lupus erythematosus after induction of ovulation. J Rheumatol. 1997;24(8):1639-1640.
6. Mok CC, Wong RW, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum. 1999; 42(6):1274-1280. doi: 10.1002/1529-0131(199906)42: 6<1274::AID-ANR26>3.0.CO;2-B
7. Levin ER. Plasma membrane estrogen receptors. Trends in Endocrinology & Metabolism. 2009; 20(10): 477-482.
8. Kisiel B, Kosińska J, Wierzbowska M, et al. Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta. Lupus. 2011; 20(1): 85-89. doi:10.1177/ 0961203310381514
9. Drehmer MN, Andrade D, Pereira IA, et al. Estrogen receptor alpha gene (ESR1) polymorphism can contribute to clinical findings in systemic lupus erythematosus patients. Lupus. 2017; 26(3): 294-298. doi:10.1177/ 0961203316668041
10. Kisiel B, Kosińska J, Wierzbowska M, et al. Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta. Lupus. 2011; 20(1): 85-89. doi:10.1177/ 0961203310381514